Thread, AWS Partner on Next Generation Technology for Clinical Trials

A North Carolina-based company is working with Amazon Web Services to create what it hopes will be a next-generation platform for conducting clinical trials.

Thread, which offers a platform for conducting decentralized clinical trials, expects the fruits of the partnership, announced Tuesday, to make trials more efficient and less expensive through greater use of artificial intelligence. and machine learning. The announcement of the

“What’s really important about this is that it’s not just about building tech for tech’s sake,” Thread co-founder and CEO John Reites said during the talk. a phone interview about working with AWS.

He said the partnership aims to help modernize clinical trials in the wake of the Covid-19 pandemic, a time when clinical trials relied more than ever on virtual and remote technology.

“Many sponsors are currently examining how they can convert a patchwork of rapidly deployed interventions, such as consumer videoconferencing and nursing home care, into a comprehensive strategic approach to trial virtualization,” wrote consultants at McKinsey & Co. in a June 2021 report on the decentralization of clinical trialss. The process typically involves bringing trials closer to patients wherever they live, rather than concentrating research in large academic medical centers and similar centralized locations.

Through their partnership, Thread and Amazon plan to focus on automating still-manual processes, generate better insights from data collected during trials, and adopt the technologies on a wider scale.

“I build the components our customers need now, but more in the next two, three or four years,” he said.
At many clinical trial sites, for example, the same data must be entered multiple times into multiple systems, he said. Thread and Amazon are building a framework to remove this need. New features could also provide more insight into why patients are dropping out of trials, allowing for better trial design, Reites said.

The partners started working together earlier this year. They plan to start rolling out new features for the Thread platform in the second quarter of 2022, Reites said. Their goals include reducing the time it takes to onboard customers who want to offer trials by 30% and saving 25% by simplifying data entry, according to Thread.

Based in Cary, NC, Thread brings over six years of industry experience. Its customers include Novartis and Procter & Gamble, many of the top 20 pharmaceutical companies, contract research organizations and hundreds of biotechnology companies. The company has 11 offices around the world.

AWS adds experience in using data and technology to improve user experience across multiple industries.

“Improvements such as AI support, automated processes, frictionless access to data, and enhanced security can advance precision medicine by reducing the time it takes to deliver innovative, life-saving medicines to patients. worldwide,” Dan Sheeran, general manager of healthcare and life sciences at Amazon Web Services, said in an email response to questions.

Apart from Thread, the decentralized clinical trials market has many players including medableCurebase and Science 37.

Photo: Warchi, Getty Images

Comments are closed.